Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02375958
Title PCA062 in pCAD-positive Tumors.
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications

esophageal cancer

triple-receptor negative breast cancer

head and neck squamous cell carcinoma

Therapies

PCA062

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP

Facility Status City State Zip Country Details
Novartis Investigative Site Houston Texas 77030 United States Details
Novartis Investigative Site San Antonio Texas 78229 United States Details
Novartis Investigative Site Villejuif Cedex 94805 France Details
Novartis Investigative Site Milano MI 20133 Italy Details
Novartis Investigative Site Koto ku Tokyo 135 8550 Japan Details
Novartis Investigative Site Singapore 169610 Singapore Details
Novartis Investigative Site Madrid 28009 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field